In recent decades, microRNAs (miRNAs) have become pivotal in cancer therapeutic strategies, serving as compelling tools and biomarkers. With dual roles as oncogenes or tumour-suppressors, miRNAs play key functions in cancer biology. Several miRNA-targeted therapeutics gaining attention have advanced to clinical development. This surge is reflected in increased miRNA integration across oncology trials, screening, diagnostics, and drug testing. Consequently, this mini-review aims to provide a succ
Recent Comments